This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The University of Texas System. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Cong-Dat Pham: Innovator in Precision Oncology
Introduction
Cong-Dat Pham is a notable inventor based in Houston, Texas. He has made significant contributions to the field of precision oncology through his innovative research and patent work. His dedication to advancing medical science is evident in his focused approach to developing new therapeutic options.
Latest Patents
Cong-Dat Pham holds a patent for "Inhibitors of the enzyme enolase for precision oncology." This patent includes compounds designed to inhibit enolase enzymes, which play a crucial role in various biological processes. The patent outlines pharmaceutical compositions that incorporate these compounds, providing methods of treatment that could enhance cancer therapies.
Career Highlights
Cong-Dat Pham is affiliated with the University of Texas System, where he engages in cutting-edge research. His work is characterized by a commitment to improving patient outcomes through innovative solutions in oncology. With a focus on precision medicine, he aims to tailor treatments to individual patient needs.
Collaborations
Some of his notable coworkers include Florian Muller and Victoria Yan. Their collaborative efforts contribute to the advancement of research in the field of oncology, fostering an environment of innovation and discovery.
Conclusion
Cong-Dat Pham's contributions to precision oncology through his patent work exemplify the impact of innovative research in medicine. His dedication to developing effective treatments showcases the importance of continued exploration in the field.